TY - JOUR AU - Ye, Lucille L. PY - 2016 TI - Professor Charles E. Geyer: neoadjuvant therapy is becoming standard of care for HER2+ breast cancer JF - Chinese Clinical Oncology; Vol 5, No 5 (October 31, 2016): Chinese Clinical Oncology (Biliary Cancer: Part I­ -Guest Editor: Ghassan Abou-Alfa) Y2 - 2016 KW - N2 - Charles E. Geyer Jr. ( Figure 1 ), MD, FACP, is Professor of Medicine in the Division of Hematology, Oncology and Palliative Care, Department of Internal Medicine, at the Virginia Commonwealth University School of Medicine, and he is also an Associate Director for Clinical Research at Virginia Commonwealth University Massey Cancer Center. UR - https://cco.amegroups.org/article/view/12077